Abstract: Disclosed are a method and an apparatus for controlling distributed transmission power in device-to-device (D2D) communication. The D2D devices individually control their transmission power for the D2D communication link. In addition, a first terminal calculates the transmission power based on the measured channel gain and interference-plus-noise level. The first terminal determines optimal transmission power based on the calculated transmission power by the first terminal, and transmits a transmission power change message including the optimal transmission power to a second terminal. Next, the second terminal transmits a D2D signal based on the optimal transmission power.

Abstract: The present invention relates to a composition including neural cells and an elastin-like polypeptide for treating Parkinson's diseases. More particularly, the present invention relates to a composition for treating Parkinson's diseases, which can more effectively increase a survival rate and settling rate of neural cells transplanted to an acutely or chronically damaged nerve region for treatment of Parkinson's disease, by simultaneously administering an elastin-like polypeptide with neural cells.

Abstract: The present invention relates to an apparatus and method for transmitting/receiving streaming data using multiple paths, in which the streaming data is smoothly reproduced without being interrupted, and more particularly, to an apparatus and method for transmitting/receiving streaming data using multiple paths, in which exchange of the streaming data is performed in real-time using the multiple paths regardless of obstacles. The method for transmitting streaming data using multiple paths includes managing and maintaining a path list including sequence information about a transmission path capable of transmitting data, framing the streaming data, and transmitting the framed streaming data via the transmission path according to the sequence information.

Abstract: The present invention relates to a method and an apparatus for processing a signal, which are used for effectively reproducing an audio signal, and more particularly, to a method and an apparatus for processing a signal, which are used for implementing binaural rendering for reproducing multi-channel or multi-object audio signals in stereo with a low calculation amount.

Abstract: Disclosed are a customized scent diffusing device and a customized scent diffusing method for effectively transferring sensibility which can be felt from contents to a user by diffusing a most appropriate scent by synchronization with digital contents. According to various exemplary embodiments of the present invention, although odor effect information in 4D contents does not correspond to a spice cartridge configuration in a scent diffusing device, an appropriate odor can be provided through combining or mixing spice cartridges in the scent diffusing device.

Abstract: A pixel driving method comprises the following steps: receiving a display image comprising a plurality of image points, wherein each image point corresponds a display color; producing a first sub-image and a second sub-image according to the display image, wherein the first sub-image displays a part of the image points, while the second sub-image displays the other part of the image points; and displaying at least one of the first sub-image and the second sub-image on the color display panel.

Abstract: Provided is a stretchable transparent electrode including a first substrate having an uneven surface, a first conductive film conformally covering the uneven surface of the first substrate to have an uneven top surface, a second conductive film conformally covering the first conductive film to have an uneven top surface, and a second substrate covering the second conductive film, wherein one of the first and second conductive films is a metal film and the other is a graphene film.

Abstract: A vaccine composition for birds comprising as an active ingredient a structure containing O-antigen derived from Gram-negative bacteria, provided that said structure does not contain a whole cell, and a process for preparing the same are provided. By using a structure containing O-antigen (e.g. lipopolysaccharide) derived from Gram-negative bacteria as an active ingredient in accordance with the present invention, alleviation of inoculation reaction and reduction in an amount of injection are attained as compared to the conventional whole-cells vaccine to thereby allow for the increase in the number of other antigens to be mixed therewith.

Abstract: Disclosed herein are an RCAS and a request processing method for the RCAS. The request processing method according to an embodiment includes validating, by a Distributed Authorization Center (DAC), a join request or a leave request transmitted from a Set-Top Box (STB), sending, by the DAC, a report message to a Centralized Authorization Center (CAC) when validation has succeeded, updating, by the CAC, a database (DB) related to a state of the STB, based on the report message, and sending a certificate state update message including information about the update to DACs of one or more additional head-ends.

Abstract: Electronic logic gates that operate using N logic state levels, where N is greater than 2, and methods of operating such gates. The electronic logic gates operate according to truth tables. At least two input signals each having a logic state that can range over more than two logic states are provided to the logic gates. The logic gates each provide an output signal that can have one of N logic states. Examples of gates described include NAND/NAND gates having two inputs A and B and NAND/NAND gates having three inputs A, B, and C, where A, B and C can take any of four logic states. Systems using such gates are described, and their operation illustrated. Optical logic gates that operate using N logic state levels are also described.

Abstract: A layer protecting the surface of zirconium alloys used as materials for nuclear reactors is formed by a homogenous polycrystalline diamond layer prepared by chemical vapor deposition method. This diamond layer is 100 nm to 50 ?m thick and the size of the crystalline cores in the layer ranges from 10 nm to 500 nm. Maximum content of non-diamond carbon is 25 mol %, total content of non-carbon impurities is maximum up to 0.5 mol %, RMS surface roughness of the polycrystalline diamond layer has a value less than 40 nm and thermal conductivity of the layer ranges from 1000 to 1900 W?m?1??K?1. Coating of the zirconium alloys surface with the described polycrystalline diamond layer serves as a zirconium alloys surface protection against undesirable changes and processes in the nuclear reactor environment.

Abstract: Provided is a device for measuring a micro flow rate. The device includes a container having an internal space for containing a fluid flowing therein and an inflow line and an outflow line formed in communication with the internal space, a fluid level gauge configured to sense whether a level of a fluid collected in the container rises to a predetermined height to conduct or block flow of an electric current, a control valve disposed in the outflow line and configured to open or close the outflow line according to a state in which the control valve is electrically connected to or disconnected from the fluid level gauge such that the outflow line is opened or closed according to a change in the fluid level; and a control unit configured to calculate a micro flow rate of the fluid collected in the container using information acquired from at least one of the fluid level gauge and the control valve.

Abstract: An object of the present invention is to improve spinnability, productivity, and tensile strength of a polyester fiber containing poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). By spinning the polyester resin containing the poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) at a high spinning velocity, the spinnability, productivity, and tensile strength of the polyester fiber can be improved.

Abstract: The present invention relates to a pharmaceutical composition for preventing, ameliorating, or treating cancer. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating cancer including a lignan compound having a specific chemical structure (Chemical Formula 1); a health functional food composition for preventing or ameliorating cancer including the lignan compound; and a method for preventing, ameliorating, or treating cancer using the composition. Further, the present invention relates to a use of the lignan compound in the preparation of a pharmaceutical composition or a health functional food composition for preventing, ameliorating, or treating cancer.

Abstract: An improved nanoparticle for transfecting cells is provided. The nanoparticle includes a core polyplex and a silica coating on the core polyplex and, optionally, a polymer attached to an outer surface of the silica coating , where the polyplex includes an anionic polymer, a cationic polymer, a cationic polypeptide, and a polynucleotide. Also provided is an improved method of modifying intracellular polynucleotides. The method includes contacting a cell with a nanoparticle that includes a core polyplex and a silica coating on the core polyplex and, optionally, a polymer attached to an outer surface of the silica coating, where the polyplex includes an anionic polymer, a cationic polymer, a cationic polypeptide, and a polynucleotide.

Abstract: The invention relates to a method and system for smoothing the energy storage wind and photovoltaic power fluctuation based on rate control, including: reading and processing data; determining the signal change rate of the dynamic slope limiter; calculating the smoothing target value of the wind and photovoltaic total power; calculating total power demand of battery energy storage power station; and outputting data. The invention can effectively suppress wind and photovoltaic power fluctuation under the fluctuation rate limited value, can effectively smooth wind and photovoltaic power output. Thus it smoothens wind and photovoltaic power output, reduces the energy storage battery burden, and effectively controls battery energy storage power station system.

Abstract: The present disclosure discloses an electrical switchgear configured to control an electro-magnet by using the electro-magnet, a critical temperature device, and an electro-magnet control unit without using a bimetal and a mechanical contact. The electro-magnet switches power applied through a power line in response to a flow of control current to a power device connected to a load side. In a critical temperature device, an output current value varies when a temperature of a heating wire, which is connected to the power line, exceeds a critical temperature by supply current flowing to the power device. An electro-magnet control unit, which is realizable with an SCR, allows a flow of control current of the electro-magnet to be generated or cut off in response to the output current value of the critical temperature device.

Abstract: The present invention relates to an ion trap mass spectrometer using a cold electron source, in a production of a portable mass spectrometer, in which a microchannel plate (MCP) module is used, initial electrons are induced by injecting ultraviolet photons emitted from an ultraviolet diode to a front surface of the MCP module, electron beams amplified from the electrons are amplified using a channeltron electron multiplier (CEM), the amplified electron beams are accurately adjusted and injected into an ion trap, thus increasing the amplification rate, and since a quadrupole field is used as an ion filter which returns the initially injected electrons to the inside of an ion trap mass separator, the ionization rate increases.

Abstract: The disclosure provides a pharmaceutical composition. The pharmaceutical composition includes a chitosan with palmitoyl groups and an active agent. According to another embodiment, the pharmaceutical composition can further include a gelling accelerating agent. According to an embodiment of the disclosure, the active agent of the disclosure can be administered in the form of a nano-drug, liposome, micelle, or microparticle.

Abstract: The present invention provides a porous material having micropores capable of storing and releasing heat by phase change, which comprises a phase change material inserted into the micropores of a porous material medium such as activated carbon or silica gel so as to be capable of storing and releasing energy, and a preparation method thereof. The method comprises the steps of: pre-treating a porous material medium to remove impurities from the micropores of the porous material medium, thereby opening the micropores; pre-treating a phase change material to make it possible to insert the phase change material into the micropores of the porous material medium; inserting the pretreated phase change material into the pretreated porous material medium; filtering the porous material medium filled with the phase change material to remove the phase change material remaining after the insertion step; and washing the filtered material.